The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
340B Link
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Omnicell, a leading provider of medication management solutions and adherence tools for health systems and pharmacies, on the acquisition of the 340B Link business from Pharmaceutical Strategies Group (PSG)
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Cello Health plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States
![Denmark Denmark flag](https://www.greenhill.com/sites/default/files/denmark_flag%5B1%5D.gif)
Global collaboration agreement with Genmab A/S
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised AbbVie, Inc, an NYSE-listed global biopharmaceutical company, on a broad collaboration with Genmab A/S, a leading Danish-listed biotechnology company, to jointly develop and commercialise three next-generation bispecific antibody programs
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Cerner RevWorks
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Cerner Corporation, a leader in healthcare information technology, on its sale of its RevWorks revenue cycle management services business to R1 RCM, a leading provider of technology-enabled RCM services
![](https://www.greenhill.com/sites/default/files/lang-ca-us.png)
Abacus Health Products, Inc.
![](https://www.greenhill.com/sites/default/files/lang-ca-us.png)
Advised Abacus Health Products, Inc., a leader in over-the-counter (“OTC”) topical products combining active pharmaceutical ingredients with cannabidiol (“CBD”) hemp extract, on its sale to the Charlotte’s Web Holdings, Inc., a market leader in hemp-derived CBD wellness products.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
OurHealth
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised OurHealth, a provider of onsite and near-site employer-sponsored primary care clinics, on its sale to General Atlantic and merger with Marathon Health
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
CME Group Inc.
![Malaysia Malaysia flag](https://www.greenhill.com/sites/default/files/malaysia_63832.gif)
Advised CME Group, Inc., the operator of a leading global derivatives marketplace, on the structured sale of its 25% equity stake in Bursa Malaysia Derivatives Berhad to Bursa Malaysia Berhad
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
TT International
![Japan Japan flag](https://www.greenhill.com/sites/default/files/japan.gif)
Advised TT International, a leading independent asset management firm focused on managing high alpha, high conviction active management strategies for institutional investors, on its sale to Sumitomo Mitsui Financial Group, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
M&T Bank's Ownership Interest in Cramer Rosenthal McGlynn
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised M&T Bank on the sale of its ownership interest in Cramer Rosenthal McGlynn to the company's management team
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Total System Services, Inc. (TSYS)
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Total System Services, Inc. (TSYS), a provider of payment processing, merchant services and related payment services, on its merger with Global Payments Inc., a payment technology company focused on merchant acquiring and software solutions
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Pfizer Inc. Consumer Health Business
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised GlaxoSmithKline plc ("GSK"), the UK listed international pharmaceutical and consumer healthcare company, on the combination of GSK's and Pfizer's Consumer Health businesses to create a world-leading Joint Venture
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Starpharma Holdings Limited, patented VivaGel BV® product
![Italy, USA flags](https://www.greenhill.com/sites/default/files/italian-us-flag.png)
Advised Starpharma Holdings Limited on a US licensing agreement of its patented VivaGel BV® product with ITF Pharma, a US subsidiary of Italfarmaco S.p.A., a privately held European specialty pharmaceutical company
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Aisthesis
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Aisthesis, a portfolio company of Triton Pacific Capital Partners, on its sale to NAPA, a portfolio company of American Securities
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Blue Sky Alternative Investments Limited
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Blue Sky, an ASX-listed diversified alternative assets manager, on its response to an activist short-seller campaign, strategic review of recapitalisation options, and receipt of a A$50mm long-term capital investment by Oaktree via a 7-year senior secured convertible loan note facility
![Canada Canada flag](https://www.greenhill.com/sites/default/files/canada.gif)
Common shares and common share purchase warrants in Canopy Growth
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Canopy Growth on a C$5bn investment by Constellation Brands. As consideration for the investment, Constellation received newly issued Canopy common shares and common share purchase warrants
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Walmart (Credit Card Assets)
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Walmart Inc. on its new, long term credit card program agreement with Capital One Financial Corporation
![Canada Canada flag](https://www.greenhill.com/sites/default/files/canada.gif)
Concordia International Corp.
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised an Ad Hoc Group of Cross-over Debtholders on Concordia International’s cross-border Canadian restructuring and recapitalization, including a US$586.5mm common equity private placement, the equitization of ~US$1.7bn of unsecured debt and the partial paydown and exchange of ~US$2.2bn of secured debt
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Cayan, LLC
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Total System Services, a provider of payment processing, merchant services and related payment services, on acquiring Cayan, a payment technology company focused on integrated solutions and merchant acquiring
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
L.L.Bean (Credit Card Assets)
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised L.L.Bean Inc. on a strategic alliance relating to its credit card business with Citibank, N.A.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Wells Fargo Share Registration & Service business
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised Equiniti Group plc, a UK based specialist technology outsourcer providing non-discretionary payment and administration services, on the acquisition of Wells Fargo's Shareowner Services business, and acted as joint sponsor to Equiniti's associated £122 million rights issue
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Derma Sciences, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Derma Sciences, Inc., a tissue regeneration company focused on advanced wound and burn care, on its sale to Integra LifeSciences Holdings Corporation, a global leader in medical technology
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Palatin Technologies, Inc. lead product candidate, Rekynda
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Palatin Technologies, Inc. on the exclusive licensing of North American rights to develop and commercialize RekyndaTM (bremelanotide), an investigational product designed for on-demand treatment for hypoactive sexual desire disorder in pre-menopausal women, to AMAG Pharmaceuticals, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Gradifi, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised First Republic Bank, a provider of private banking, private business banking and private wealth management services, on the acquisition of Gradifi, a Boston-based technology and service platform used by employers to make direct contributions to employees’ student loans
![USA/Canada U.S.A., Canada flags](https://www.greenhill.com/sites/default/files/usa_canada.gif)
Concordia International Corp
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised the Special Committee of the Board of Directors of Concordia International, a diverse, international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, on its strategic review process
![USA/UK U.S.A., U.K. flags](https://www.greenhill.com/sites/default/files/usa_uk.gif)
US rights to Toprol-XL (AstraZeneca)
![Canada Canada flag](https://www.greenhill.com/sites/default/files/canada.gif)
Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the US rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.